Cargando…
一例化疗联合免疫治疗无效胰腺癌患者再联合靶向治疗有效
A 68-year-old male was admitted due to fatigue and poor appetite and diagnosed pathologically as pancreatic adenocarcinoma with liver metastasis. The tumor marker carbohydrate antigen 199 (CA199) level was 2003.4 U/mL. The patient received two cycles of modified FOLFIRINOX plus immune checkpoint inh...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
《浙江大学学报》编辑部
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630052/ https://www.ncbi.nlm.nih.gov/pubmed/37899397 http://dx.doi.org/10.3724/zdxbyxb-2023-0258 |
Ejemplares similares
-
选择性动脉灌注化疗联合靶向药物治疗非小细胞肺癌多发脑转移
Publicado: (2012) -
肺鳞癌靶向治疗研究现状
Publicado: (2013) -
新辅助免疫治疗及联合化疗在NSCLC中的研究进展
Publicado: (2021) -
新型分子靶向药物联合放疗在肺癌中的应用
por: PROVENCIO, Mariano, et al.
Publicado: (2010) -
肺鳞癌分子靶向治疗的研究现状
Publicado: (2014)